CTOs on the Move

Northwest Pharmacy Svc

www.nwpsrx.com

 
Northwest Pharmacy Svc is a Enumclaw, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.nwpsrx.com
  • 2479 Griffin Ave Ste 102
    Enumclaw, WA USA 98022
  • Phone: 800.998.2611

Executives

Name Title Contact Details

Similar Companies

Byte Sized Solutions

Byte Sized Solutions is a Palatine, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

FORBA

FORBA is a Pueblo, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Holmes Lake Manor

Holmes Lake Manor is a Lincoln, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Neosho Memorial Regional Medical Center

Neosho Memorial Regional Medical Center is a Chanute, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MRI Interventions

MRI Interventions, Inc. is a medical device company that develops and commercializes innovative platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging, or MRI, guidance. Since our inception in 1998, we have focused on research and product development in the field of interventional MRI. From 1998 to 2002, we deployed significant resources to fund our efforts to develop the foundational capabilities for enabling MRI-guided interventions and to build an intellectual property position. In 2003, our focus shifted to identifying and building out commercial applications for the technologies we developed in prior years. We have two product platforms. Our ClearPoint® system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. Our ClearTrace system, which is still in development, will be used to perform minimally invasive surgical procedures in the heart. Both systems utilize intra-procedural magnetic resonance imaging to guide the procedures. Both systems are designed to work in a hospital’s existing MRI suite. Our products are designed to provide a new, minimally invasive surgical approach for the benefit of large patient populations. Our ClearPoint system is designed to enable the delivery of therapies to treat certain neurological diseases. Our ClearTrace system is designed to deliver therapies to treat certain cardiac diseases. We believe that our two product platforms, subject to appropriate regulatory clearance and approval, will provide better patient outcomes, enable physicians and hospitals to treat more patients, and reduce costs to the healthcare system.